論文

査読有り 国際誌
2016年3月

Effectiveness of peroral direct cholangioscopy using an ultraslim endoscope for the treatment of hepatolithiasis in patients with hepaticojejunostomy (with video).

Surgical endoscopy
  • Kazuyuki Matsumoto
  • Koichiro Tsutsumi
  • Hironari Kato
  • Yutaka Akimoto
  • Daisuke Uchida
  • Takeshi Tomoda
  • Naoki Yamamoto
  • Yasuhiro Noma
  • Shigeru Horiguchi
  • Hiroyuki Okada
  • Kazuhide Yamamoto
  • 全て表示

30
3
開始ページ
1249
終了ページ
54
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s00464-015-4323-6

BACKGROUND: Hepatolithiasis is a postoperative complication of hepaticojejunostomy (HJ) performed for various pancreatobiliary diseases. Hepatolithiasis can cause repeated cholangitis. Complete stone removal and bile stasis elimination are therefore necessary. Here, we evaluated the effectiveness of peroral direct cholangioscopy (PDCS) using an ultraslim endoscope for treating hepatolithiasis in HJ patients. METHODS: We studied 14 patients with hepatolithiasis who underwent bowel reconstruction with HJ between April 2012 and May 2014. Diagnostic and therapeutic endoscopic retrograde cholangiography using a short double-balloon enteroscope (DBE) was initially performed. Following stone removal, the DBE was exchanged for an ultraslim endoscope through the balloon overtube for PDCS. RESULTS: The success rate of PDCS procedure was 85.7% (12/14). In 5 of 12 (41.7%) patients with successful PDCS, the residual stones were detected and removed completely using a 5-Fr basket catheter and suction after normal saline irrigation. In the remaining 7 (58.3%) patients, no residual stone was detected. The median procedure time was 14 min (range 8-36) with no serious postoperative complications. The median follow-up time after PDCS was 21 months (range 5-26), and only 1 patient (8.3%) had IHBD stone recurrence with an anastomotic stricture. CONCLUSIONS: PDCS using an ultraslim endoscope appears to be useful for detecting and removing residual stones following hepatolithiasis treatment using a DBE. The combined use of a DBE and PDCS may reduce the risk of hepatolithiasis recurrence in HJ patients.

リンク情報
DOI
https://doi.org/10.1007/s00464-015-4323-6
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/26123333
ID情報
  • DOI : 10.1007/s00464-015-4323-6
  • PubMed ID : 26123333

エクスポート
BibTeX RIS